​

Funding Round

Series A - ReNAgade Therapeutics

Series A - ReNAgade Therapeutics

Investment Firm

Overview

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

Announced Date

May 23, 2023

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

F2 Ventures

F2 Ventures

F2 Ventures is a early_stage_venture and late_stage_venture firm.

Participant Investors

2

Investor Name
Participant InvestorF2 Ventures
Participant InvestorMPM Capital

Round Details and Background

ReNAgade Therapeutics raised $300000000 on 2023-05-23 in Series A

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 23, 2023
Series A - ReNAgade Therapeutics
2-300.0M

Recent Activity

There is no recent news or activity for this profile.